Erichsen C, Christensson P I, Jakobsson B, Eriksson G, Yngner T, Jönsson P E, Stenram U
Anticancer Res. 1987 Jan-Feb;7(1):77-80.
Cytostatic treatment of liver metastases from colorectal cancer has been of limited value. Higher drug levels in the target substances of the tumor may improve the results. It was the aim of this investigation to examine the effect of PALA (N-phosphonacetyl-L-aspartate) and D-glucosamine on the level of uracil nucleotides in the liver and in an N-methyl-N-nitrosoguanidine-induced adenocarcinoma of the colon transplanted to the liver of rats, and on the incorporation of 3H-FUrd into the acid-soluble fraction, the RNA and the DNA of the tumor and of several normal tissues. Combined treatment with PALA and D-glucosamine reduced the UTP pool in the liver and the tumor. D-glucosamine alone increased UDP-N-acetyl-hexosamine in liver tissue. Pretreatment with PALA and D-glucosamine increased incorporation of 3H-FUrd into RNA of the liver and kidney, and into the DNA fraction of the liver, but had no effect on 3H-FUrd incorporation in the tumor.
细胞毒性药物治疗结直肠癌肝转移的价值有限。肿瘤靶物质中较高的药物水平可能会改善治疗效果。本研究的目的是检测PALA(N-膦酰乙酰-L-天冬氨酸)和D-葡萄糖胺对大鼠肝脏以及移植到大鼠肝脏的N-甲基-N-亚硝基胍诱导的结肠腺癌中尿嘧啶核苷酸水平的影响,以及对3H-氟尿苷掺入肿瘤和几种正常组织的酸溶性部分、RNA和DNA的影响。PALA和D-葡萄糖胺联合治疗降低了肝脏和肿瘤中的UTP池。单独使用D-葡萄糖胺可增加肝组织中UDP-N-乙酰己糖胺的含量。PALA和D-葡萄糖胺预处理可增加3H-氟尿苷掺入肝脏和肾脏的RNA以及肝脏的DNA部分,但对3H-氟尿苷掺入肿瘤没有影响。